598 related articles for article (PubMed ID: 30285732)
21. Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection.
Sumbal S; Javed A; Afroze B; Zulfiqar HF; Javed F; Noreen S; Ijaz B
Exp Hematol; 2018 Sep; 65():17-28. PubMed ID: 29940219
[TBL] [Abstract][Full Text] [Related]
22. The cornerstone of integrating circulating tumor DNA into cancer management.
Li Z; Yi L; Gao P; Zhang R; Li J
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):1-11. PubMed ID: 30419316
[TBL] [Abstract][Full Text] [Related]
23. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
Alix-Panabières C; Pantel K
Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
[TBL] [Abstract][Full Text] [Related]
24. A Pipeline for ctDNA Detection Following Primary Tumor Profiling Using a Cancer-Related Gene Sequencing Panel.
Nishizuka SS; Sato KA; Hachiya T
Methods Mol Biol; 2019; 1908():229-241. PubMed ID: 30649732
[TBL] [Abstract][Full Text] [Related]
25. Considerations for the use of circulating tumor DNA sequencing as a screening tool in cancer predisposition syndromes.
Paramathas S; Guha T; Pugh TJ; Malkin D; Villani A
Pediatr Blood Cancer; 2020 Dec; 67(12):e28758. PubMed ID: 33047872
[TBL] [Abstract][Full Text] [Related]
26. Circulating Cell-Free DNA and Cancer Therapy Monitoring: Methods and Potential.
Gahan PB
Methods Mol Biol; 2019; 1909():31-46. PubMed ID: 30580421
[TBL] [Abstract][Full Text] [Related]
27. Dynamic Treatment Stratification Using ctDNA.
Vidal J; Taus A; Montagut C
Recent Results Cancer Res; 2020; 215():263-273. PubMed ID: 31605234
[TBL] [Abstract][Full Text] [Related]
28. Liquid biopsy: unlocking the potentials of cell-free DNA.
Chu D; Park BH
Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157
[TBL] [Abstract][Full Text] [Related]
29. Circulating-tumor DNA as an early detection and diagnostic tool.
Butler TM; Spellman PT; Gray J
Curr Opin Genet Dev; 2017 Feb; 42():14-21. PubMed ID: 28126649
[TBL] [Abstract][Full Text] [Related]
30. [Progress of circulating tumor DNA methylation for gastric cancer screening and management].
Cao QX; Yan L; Hou NY; Chen JF; Yu S; Lu HJ; Dan ZJ; Pang MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):535-544. PubMed ID: 38778696
[TBL] [Abstract][Full Text] [Related]
31. Opportunities of circulating tumor DNA in lung cancer.
Wu TH; Hsiue EH; Yang JC
Cancer Treat Rev; 2019 Aug; 78():31-41. PubMed ID: 31326635
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer.
Yang F; Tang J; Zhao Z; Zhao C; Xiang Y
Reprod Biol Endocrinol; 2021 Dec; 19(1):178. PubMed ID: 34861867
[TBL] [Abstract][Full Text] [Related]
33. Grail to pour $1 billion into blood test to detect early cancer.
Sheridan C
Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
[No Abstract] [Full Text] [Related]
34. Assessment of circulating copy number variant detection for cancer screening.
Molparia B; Nichani E; Torkamani A
PLoS One; 2017; 12(7):e0180647. PubMed ID: 28686671
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumor DNA detection in lung cancer patients before and after surgery.
Guo N; Lou F; Ma Y; Li J; Yang B; Chen W; Ye H; Zhang JB; Zhao MY; Wu WJ; Shi R; Jones L; Chen KS; Huang XF; Chen SY; Liu Y
Sci Rep; 2016 Sep; 6():33519. PubMed ID: 27641744
[TBL] [Abstract][Full Text] [Related]
36. Circulating tumor DNA: from discovery to clinical application in breast cancer.
Xu J; Gao H; Guan X; Meng J; Ding S; Long Q; Yi W
Front Immunol; 2024; 15():1355887. PubMed ID: 38745646
[TBL] [Abstract][Full Text] [Related]
37. Utilizing circulating tumour DNA in radiation oncology.
Rostami A; Bratman SV
Radiother Oncol; 2017 Sep; 124(3):357-364. PubMed ID: 28735685
[TBL] [Abstract][Full Text] [Related]
38. Opportunities, Challenges, and Prospects in Electrochemical Biosensing of Circulating Tumor DNA and its Specific Features.
Campuzano S; Serafín V; Gamella M; Pedrero M; Yáñez-Sedeño P; Pingarrón JM
Sensors (Basel); 2019 Aug; 19(17):. PubMed ID: 31480367
[TBL] [Abstract][Full Text] [Related]
39. Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.
Abbosh C; Birkbak NJ; Swanton C
Nat Rev Clin Oncol; 2018 Sep; 15(9):577-586. PubMed ID: 29968853
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor DNA-From bench to bedside.
Lim JSJ; Janku F; Yap TA
Curr Probl Cancer; 2017; 41(3):212-221. PubMed ID: 28416241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]